Second International Symposium on Infections in the Immunocompromised Host

Infections in the Immunocompromised Host

The population of immunocompromised patients has multiplied greatly in recent years due to an expansion of indications for immunosuppressive therapies combined with improved survival following organ and bone marrow transplantation, cancer chemotherapy, and other chronic diseases requiring immunosuppressive therapy. Despite advances in prophylactic strategies and antimicrobial therapies, infecti...

Pulmonary infections in the immunocompromised host.

The expression "immunocompromised host" refers to an individual who has one or more defects in the body's natural defense, which leads to severe, often life-threatening, infections. Alcoholism, diabetes mellitus, advanced age, the use of antacids, and viral infections have immune-modulating effects. The human immunodeficiency virus, cytomegalovirus, Epstein-Barr virus, and Non A, Non B hepati...

Second International Lygus Symposium

XIth International Symposium on Respiratory Viral Infections

Infections Jessica A. Belser, Cynthia B. Snider, Nancy J. Cox, Frederick G. Hayden Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA. International Activities, Wellcome Trust, London, UK. Corresponde...

VII International Symposium on Respiratory Viral Infections.

The VII International Symposium on Respiratory Viral Infections was a multidisciplinary forum for the presentation of recent advances in respiratory virus research with special emphasis on antiviral therapies and vaccine strategies. Topics covered in invited lectures included detection of novel respiratory viral pathogens and viral evolution, characterization of the 1918 pandemic virus, human m...